The domestic launch of the new epilepsy drug, ‘Fycompa’ came close
The domestic launch of a new epilepsy drug is approaching.
The Ministry of Food and Drug Safety approved commercialization of the Eisai’s anti-epilepsy drug, ‘Fycompa(perampanel)’ on the 10th.
Fycompa were approved in 6 types of volume, such as 2mg, 4mg, 6mg, 8mg and 10mg, and has acquired 6 ye...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
